Cataract Surgery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

Cataract Surgery Devices Market Summary

• The global cataract surgery devices market is expected to increase from USD 8,703.96 million in 2024 to USD 12,866.16 million by 2032, reflecting strong and sustained growth.
• The global cataract surgery devices market is growing at a CAGR of 5.07% during the forecast period from 2025 to 2032.
• The market of cataract surgery devices is being primarily driven by the growing prevalence of cataracts and vision impairment, the increasing prevalence of lifestyle disorders that develop cataracts, the rising geriatric population, and an increase in product development activities among the key market players.
• The leading companies operating in the cataract surgery devices market include Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.
• North America is expected to dominate the cataract surgery devices market due to the high prevalence of cataracts among the aging population, advanced healthcare infrastructure, and strong adoption of innovative surgical technologies such as femtosecond lasers and premium intraocular lenses (IOLs). Additionally, favorable reimbursement policies, growing awareness of minimally invasive eye surgeries, and the presence of leading market players in the region further strengthen its market leadership.
• In the product type segment of the cataract surgery devices market, the intraocular lenses category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Cataract Surgery Devices Market

• The growing prevalence of cataracts and vision impairment is leading to a surge in cataract surgery devices: The growing prevalence of cataracts and vision impairment, particularly among the aging population, is driving a significant surge in demand for cataract surgery devices. As cataracts remain one of the leading causes of blindness globally, the increasing awareness, improved access to healthcare, and advancements in surgical technologies have led to a rise in surgical procedures. This trend is fuelling the market for innovative devices such as intraocular lenses, phacoemulsification systems, and femtosecond lasers, as healthcare systems prioritize effective and minimally invasive solutions to restore vision.
• The increasing prevalence of lifestyle disorders is contributing to the development of cataracts: The increasing prevalence of lifestyle disorders such as diabetes, obesity, and hypertension is contributing to the early onset of cataracts, thereby escalating the demand for cataract surgery devices. These conditions accelerate lens degeneration, leading to vision impairment at younger ages. As a result, the need for advanced surgical interventions and devices, including intraocular lenses and laser systems, is growing rapidly, further boosting the cataract surgery devices market.
• Rising geriatric population: The rising geriatric population is a major factor boosting the market for cataract surgery devices, as aging is one of the primary risk factors for cataract development. With more people living longer, the number of individuals requiring cataract treatment is steadily increasing. This growing demand is driving advancements and sales in surgical devices such as intraocular lenses and phacoemulsification equipment, supporting the expansion of the market.

Cataract Surgery Devices Market Report Segmentation

This cataract surgery devices market report offers a comprehensive overview of the global cataract surgery devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Viscosurgical Devices, and Others), End-Users (Hospitals, Specialty Clinics, and Ambulatory Surgical Centres), and Geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing cataract surgery devices market.

Cataract surgery devices encompass the entire range of instruments, equipment, and artificial implants used by ophthalmologists to treat cataracts. The primary objective of these devices is to remove the eye's clouded natural lens and replace it with a clear, artificial lens (an intraocular lens or IOL) to restore vision.

The cataract surgery devices market is being significantly boosted by several key factors. The growing prevalence of cataracts and vision impairment is driving a higher demand for surgical interventions to restore vision. This trend is further intensified by the increasing prevalence of lifestyle disorders such as diabetes, obesity, and hypertension, which accelerate cataract development. Additionally, the rising geriatric population expands the patient pool, as older adults are more susceptible to age-related eye conditions. Alongside these demand-side factors, an increase in product development activities by key market players focusing on innovative technologies such as femtosecond lasers, advanced intraocular lenses, and minimally invasive surgical devices is enhancing treatment options and further propelling market growth.

What are the latest Cataract Surgery Devices Market Dynamics and Trends?

The cataract surgery devices market is witnessing strong growth driven by the rising incidence of cataracts and vision impairments, compounded by associated risk factors such as diabetes, hypertension, and an expanding aging population. According to DelveInsight (2025), around 2.4 billion people globally are affected by near or distance vision impairment, yet only 36.5% of those with refractive errors and just 17% with cataract-related impairments have access to effective interventions. This significant treatment gap underscores the unmet need for advanced surgical solutions, thereby fuelling demand for cataract surgery devices. Aging remains the leading risk factor, with the global population aged 60 and above projected to nearly double from 12% in 2015 to 22% by 2050, reaching 2.1 billion. Given that cataracts primarily affect older adults, this demographic shift is expected to substantially increase the demand for cataract procedures.

Technological innovations and product approvals are further propelling the market. For instance, in June 2024, Alcon received FDA approval for its UNITY Cataract System and UNITY Vitreoretinal Cataract System, which integrate advanced technologies like UNITY 4D Phaco to deliver greater surgical precision, stability, and efficiency with reduced energy usage. Such advancements are expanding the capabilities of ophthalmic surgeons while improving patient outcomes. Moreover, growing healthcare infrastructure in emerging economies, rising awareness of eye health, and favourable reimbursement frameworks in developed regions are collectively supporting market expansion.

However, challenges such as surgical complications, including posterior capsule opacification, cystoid macular edema, retinal detachment, and infection, remain key barriers that may restrain long-term market growth. Nonetheless, with the growing burden of cataract-related blindness, supportive public health initiatives, and continuous innovation, the cataract surgery devices market is expected to experience robust growth between 2025 and 2032.

Cataract Surgery Devices Market Segment Analysis

Cataract Surgery Devices Market by Product Type (Phacoemulsification Systems, Femtosecond Lasers, Intraocular Lenses, Viscosurgical Devices, and Others), End-Users (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: Intraocular Lenses Category Dominates the Market

In the product type segment of the cataract surgery devices market, intraocular lenses (IOLs) are expected to account for the largest share, representing 47% in 2024. This dominance is attributed to their critical role in restoring vision after cataract removal, making them indispensable in cataract surgery. Advances in IOL technology, such as multifocal, trifocal, toric, and extended depth-of-focus lenses, have significantly enhanced patient outcomes by improving near, intermediate, and distance vision. Rising patient awareness of premium IOL options, coupled with the demand for minimally invasive procedures and advanced surgical techniques, is further driving adoption. Strong product pipelines from leading manufacturers, along with continuous innovations in lens materials and designs, reinforce the leadership position of IOLs in this market.

This growth is also supported by robust R&D and ongoing product development worldwide, aimed at refining cataract surgery outcomes. For instance, in October 2024, Bausch + Lomb announced FDA approval of the Envista Envy IOL, designed to deliver improved visual outcomes for cataract patients.

Therefore, supported by technological advancements, increasing patient preference for premium solutions, and strong industry pipelines, the intraocular lens segment is expected to remain the primary revenue contributor, propelling overall growth of the global cataract surgery devices market during the forecast period.

By End-Users: Hospitals Dominate the Market

Hospitals are playing a pivotal role in driving the growth of the cataract surgery devices market, serving as the primary centers for surgical interventions, post-operative care, and patient management. Equipped with advanced infrastructure, skilled ophthalmic surgeons, and access to cutting-edge technologies such as phacoemulsification systems, femtosecond lasers, and premium intraocular lenses, hospitals enable the rapid adoption of innovative surgical solutions. They also contribute to raising awareness through outreach programs, eye camps, and public health initiatives, which expand patient access to timely diagnosis and treatment. Furthermore, the increasing preference for hospital-based cataract procedures, driven by their ability to offer comprehensive care, higher safety standards, and favorable reimbursement policies, further strengthens their role in boosting device utilization. Growing investments in modern surgical equipment, coupled with the rising demand for minimally invasive and precision-based procedures, continue to make hospitals a key growth driver in the global cataract surgery devices market.

Cataract Surgery Devices Market Regional Analysis

North America Cataract Surgery Devices Market Trends

North America is projected to hold the largest share of the cataract surgery devices market in 2024, accounting for 39% of the global market. This growth is primarily driven by the rising prevalence of cataracts and other vision-impairing disorders, coupled with risk factors such as an aging population, diabetes, and hypertension. According to the National Institutes of Health (2023), over 50% of individuals aged 80 and above in the U.S. had cataracts or had undergone cataract surgery. Similarly, CDC data (2024) reported that an estimated 20.5 million Americans aged 40 and older were affected by cataracts in 2022. This substantial patient pool continues to fuel demand for advanced surgical technologies, including phacoemulsification systems, intraocular lenses, femtosecond lasers, and ophthalmic viscosurgical devices, that improve surgical precision, efficiency, and outcomes.

Demographic trends further amplify market growth, as the U.S. geriatric population is projected to expand significantly. The Population Reference Bureau (2025) estimates that the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million by 2050, making age-related eye conditions like cataracts increasingly prevalent. In response, hospitals and specialty eye clinics are adopting advanced cataract surgery platforms, supported by favorable reimbursement policies and high healthcare spending in the region.

Ongoing R&D and product innovation also strengthen market expansion. For example, in July 2024, Oertli Instrumente AG received U.S. FDA 510(k) clearance for the Faros anterior cataract surgery system, a next-generation platform offering advanced fluidics and vacuum control to optimize outcomes across varying cataract hardness levels. The strong presence of leading global manufacturers, coupled with continuous technological innovation and patient awareness programs, further reinforces North America's leadership in the cataract surgery devices market.

Therefore, the combination of a large patient base, demographic shifts, robust healthcare infrastructure, and ongoing innovation is expected to significantly bolster market growth in North America during the forecast period.

Europe Cataract Surgery Devices Market Trends

Europe is driving the growth of the cataract surgery devices market through a combination of an aging population, advanced healthcare infrastructure, and high patient awareness of eye care. The region has a large pool of geriatric patients who are increasingly seeking cataract surgery to improve quality of life, fueling demand for advanced surgical devices such as phacoemulsification systems, intraocular lenses, and femtosecond lasers. For instance, as per data published by the Government of the United Kingdom (2024), in England, more than 516,073 people were admitted to hospitals for cataract surgery in 2023.

Additionally, strong government support, favorable reimbursement policies, and continuous technological innovations by key market players are enhancing surgical outcomes and expanding access to treatments, further propelling market growth in Europe. For instance, in March 2025, Alcon announced that Vivity(R), the widely implanted extended depth of focus (EDOF) intraocular lens, became available on its advanced Clareon(R) lens material. Clareon Vivity(R) received CE Mark approval and began its commercial rollout in Europe in early Q2 2025.

Thus, the factors mentioned above are expected to boost the overall market of cataract surgery devices in Europe during the forecast period.

Asia-Pacific Cataract Surgery Devices Market Trends

The Asia-Pacific cataract surgery devices market is defined by a high volume of procedures and significant unmet medical needs, driven by the region's large and aging population. The market exhibits a tiered structure, with a stark divide between urban centers, which are rapidly adopting advanced technologies like Femtosecond Laser-Assisted Cataract Surgery (FLACS) and premium intraocular lenses (IOLs), and rural areas that rely on more traditional and affordable methods. A key trend is the coexistence of high-end international manufacturers and low-cost domestic players. Furthermore, the region is seeing a rapid shift toward modern phacoemulsification techniques and is at the forefront of adopting digital health solutions and AI for surgical planning. Governments and public health organizations are also playing a crucial role by providing subsidies and launching awareness campaigns to address the huge backlog of untreated cataracts. Lastly, the growth of medical tourism in countries like India and Singapore is boosting the demand for advanced surgical devices as they offer high-quality, yet affordable, care to international patients.

Who are the major players in the cataract surgery devices market?

The following are the leading companies in the cataract surgery devices market. These companies collectively hold the largest market share and dictate industry trends.

• Alcon Inc.
• Johnson & Johnson Services, Inc.
• NIDEK CO., LTD.
• ZEISS Group
• Bausch Health Companies Inc.
• Ziemer Ophthalmic Systems AG
• Abbott Laboratories
• HOYA Corporation
• Aurolab
• Hanita Lenses Ltd.
• Topcon Corporation
• STAAR SURGICAL
• Bohus BioTech AB
• Eyekon Medical
• CIMA Technology Inc.
• Medisonic Equipments Pvt. Ltd.
• Opthalmika Ltd.
• Lumenis Be Ltd.
• Essilor International
• Oertli Instrumente AG
• Others

How is the competitive landscape shaping the cataract surgery devices market?

The competitive landscape of the cataract surgery devices market is highly dynamic and moderately concentrated, with a few key global players such as Alcon, Johnson & Johnson Vision, Bausch + Lomb, and Carl Zeiss Meditec dominating the market. These companies maintain their leadership through continuous product innovation, strategic partnerships, mergers and acquisitions, and geographic expansion. The market also sees participation from emerging players offering specialized or cost-effective solutions, increasing competition, and driving technological advancements. Overall, the combination of strong presence by established players and growing activity from new entrants is shaping a competitive environment that encourages innovation, improves surgical outcomes, and expands patient access to advanced cataract surgery devices.

Recent Developmental Activities in the Cataract Surgery Devices Market

• In April 2025, Alcon announced the launch of the UNITY(R) Vitreoretinal Cataract System (VCS) and UNITY(R) Cataract System (CS), offering a versatile platform with both a combined console (VCS) and a standalone cataract system (CS). The systems featured first-to-market technologies, including UNITY 4D Phaco, HYPERVIT(R) 30K, and the UNITY Intelligent Fluidics system, designed to improve efficiency and surgical outcomes for cataract and vitreoretinal procedures.
• In March 2025, Alcon announced that Vivity(R), the widely implanted extended depth of focus (EDOF) intraocular lens, became available on its advanced Clareon(R) lens material. Clareon Vivity(R) received CE Mark approval and began its commercial rollout in Europe in early Q2 2025.
• In September 2024, ClearView 3 Lens, a dual-lens designed to reduce glare and halos, offering a seamless visual experience, was launched by LensTech Inc.
• In July 2024, Lensar announced that the Oertli Instrumente received FDA 510(k) clearance for its Faros anterior cataract surgery system.
• In June 2024, Alcon's new UNITY Cataract and Vitreoretinal Systems received U.S. FDA 510(k) clearance.

Cataract Surgery Devices Market Segmentation

• Cataract Surgery Devices by Product Type Exposure
• Phacoemulsification Systems
• Femtosecond Lasers
• Intraocular Lenses
• Viscosurgical Devices
• Others
• Cataract Surgery Devices End-Users Exposure
• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cataract Surgery Devices Geography Exposure
• North America Cataract Surgery Devices Market
• United States Cataract Surgery Devices Market
• Canada Cataract Surgery Devices Market
• Mexico Cataract Surgery Devices Market
• Europe Cataract Surgery Devices Market
• United Kingdom Cataract Surgery Devices Market
• Germany Cataract Surgery Devices Market
• France Cataract Surgery Devices Market
• Italy Cataract Surgery Devices Market
• Spain Cataract Surgery Devices Market
• Rest of Europe Cataract Surgery Devices Market
• Asia-Pacific Cataract Surgery Devices Market
• China Cataract Surgery Devices Market
• Japan Cataract Surgery Devices Market
• India Cataract Surgery Devices Market
• Australia Cataract Surgery Devices Market
• South Korea Cataract Surgery Devices Market
• Rest of Asia-Pacific Cataract Surgery Devices Market
• Rest of the World Cataract Surgery Devices Market
• South America Cataract Surgery Devices Market
• Middle East Cataract Surgery Devices Market
• Africa Cataract Surgery Devices Market

Impact Analysis

AI-Powered Innovations and Applications:

Artificial Intelligence (AI) is transforming cataract surgery by enhancing precision, personalizing treatment, and streamlining surgical workflows. AI-powered innovations include advanced intraocular lens (IOL) power calculation models that analyze multiple ocular parameters to improve refractive outcomes, and AI-driven surgical guidance systems, such as the ALLY Adaptive Cataract Treatment System, which assist in steps like corneal incisions and capsulotomy centration to reduce variability and improve accuracy. Additionally, AI analyzes multimodal imaging data, including OCT scans, to detect subtle ocular abnormalities for informed pre-operative planning, while AI-powered surgical video analysis provides real-time feedback on technique and efficiency, supporting surgeon skill development. AI-integrated augmented reality (AR) systems further enhance surgical accuracy by overlaying critical information and phase-specific cues during procedures. Together, these AI applications are improving diagnostic precision, optimizing surgical performance, and delivering better visual outcomes, ultimately advancing patient care in cataract surgery..

U.S. Tariff Impact Analysis on Cataract Surgery Devices Market:

The U.S. tariff on cataract surgery devices has created additional cost pressures for manufacturers and importers, leading to higher prices for surgical equipment and intraocular lenses in the domestic market. These tariffs can affect the supply chain by increasing the cost of imported components and finished devices, potentially slowing down adoption rates among hospitals and surgical centers. In response, companies may seek to localize production or adjust pricing strategies to maintain competitiveness. While the tariffs may encourage domestic manufacturing, they can also pose challenges for smaller suppliers and slow the introduction of innovative technologies from international markets, ultimately influencing the overall growth dynamics of the U.S. cataract surgery devices market.

How This Analysis Helps Clients

• Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
• Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
• Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
• Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the cataract surgery devices market report study

• Market size analysis for the current cataract surgery devices market size (2024), and market forecast for 8 years (2025 to 2032)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the cataract surgery devices market.
• Various opportunities available for the other competitors in the cataract surgery devices market space.
• What are the top-performing segments in 2024? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current cataract surgery devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the cataract surgery devices market growth in the future?

Frequently Asked Questions for the Cataract Surgery Devices Market

1. What is the growth rate of the cataract surgery devices market?

• The cataract surgery devices market is estimated to grow at a CAGR of 5.07% during the forecast period from 2025 to 2032.

2. What is the market for cataract surgery devices?

• The cataract surgery devices market was valued at USD 8,703.96 million in 2024, and is expected to reach USD 12,866.16 million by 2032.

3. Which region has the highest share in the cataract surgery devices market?

• North America is expected to dominate the cataract surgery devices market due to the high prevalence of cataracts among the aging population, advanced healthcare infrastructure, and strong adoption of innovative surgical technologies such as femtosecond lasers and premium intraocular lenses (IOLs). Additionally, favourable reimbursement policies, growing awareness of minimally invasive eye surgeries, and the presence of leading market players in the region further strengthen its market leadership.

4. What are the drivers for the cataract surgery devices market?

• The cataract surgery devices market is being significantly boosted by several key factors. The growing prevalence of cataracts and vision impairment is driving a higher demand for surgical interventions to restore vision. This trend is further intensified by the increasing prevalence of lifestyle disorders such as diabetes, obesity, and hypertension, which accelerate cataract development. Additionally, the rising geriatric population expands the patient pool, as older adults are more susceptible to age-related eye conditions. Alongside these demand-side factors, an increase in product development activities by key market players focusing on innovative technologies such as femtosecond lasers, advanced intraocular lenses, and minimally invasive surgical devices is enhancing treatment options and further propelling market growth.

5. Who are the key players operating in the cataract surgery devices market?

• Some of the key market players operating in the cataract surgery Devices market include Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG, Abbott Laboratories, HOYA Corporation, Aurolab, Hanita Lenses Ltd, Topcon Corporation, STAAR SURGICAL, Bohus BioTech AB, Eyekon Medical, CIMA Technology Inc., Medisonic Equipments Pvt. Ltd., Opthalmika Ltd, Lumenis Be Ltd., Essilor International, Oertli Instrumente AG, and others.